Pharmacological properties of tetrahydropapaveroline.
D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D001001:Anura; D001464:Barium / Q000494:pharmacology; D001783:Blood Flow Velocity; D001794:Blood Pressure / Q000187:drug effects; D002415:Cats; D004285:Dogs; D004386:Duodenum / Q000187:drug effects; D004558:Electric Stimulation; D004983:Ethanolamines / Q000494:pharmacology; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects; D006325:Heart Atria / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D006632:Histamine / Q000494:pharmacology; D007082:Ileum / Q000187:drug effects; D007545:Isoproterenol / Q000494:pharmacology*; D009119:Muscle Contraction / Q000187:drug effects; D009541:Nictitating Membrane / Q000187:drug effects; D010085:Oxidative Phosphorylation / Q000187:drug effects; D010208:Papaverine / Q000494:pharmacology*; D011817:Rabbits; D012110:Reserpine / Q000494:pharmacology; D012119:Respiration / Q000187:drug effects; D012867:Skin / Q000187:drug effects; D013566:Sympathomimetics / Q000494:pharmacology*; D014439:Tyramine / Q000494:pharmacology; D014666:Vasomotor System / Q000187:drug effects
D004983:Ethanolamines; D013566:Sympathomimetics; D001464:Barium; D006632:Histamine; D012110:Reserpine; D010208:Papaverine; D007545:Isoproterenol; D000109:Acetylcholine; D014439:Tyramine